Breast cancer lung metastasis: Molecular biology and therapeutic implications

L Jin, B Han, E Siegel, Y Cui, A Giuliano… - Cancer biology & …, 2018 - Taylor & Francis
Distant metastasis accounts for the vast majority of deaths in patients with cancer. Breast
cancer exhibits a distinct metastatic pattern commonly involving bone, liver, lung, and brain …

Expert consensus document on pulmonary metastasectomy

JR Handy, RM Bremner… - The Annals of …, 2019 - annalsthoracicsurgery.org
17. When managing NSGCTs, PM is indicated for select patients with limited number of lung
abnormalities after first-line or second-line platin-based chemotherapy suspected of …

[HTML][HTML] Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032 …

A Wöckel, J Festl, T Stüber, K Brust… - Geburtshilfe und …, 2018 - thieme-connect.com
Ziele Das Ziel dieser offiziellen Leitlinie, die von der Deutschen Gesellschaft für
Gynäkologie und Geburtshilfe (DGGG) und der Deutschen Krebsgesellschaft (DKG) …

Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population‐based study

W Xiao, S Zheng, P Liu, Y Zou, X Xie, P Yu… - Cancer …, 2018 - Wiley Online Library
The risk factors for morbidity and mortality in breast cancer lung metastases (BCLM) patients
still remain poorly identified. The aim of this study was to assess the incidence and survival …

The past, present and future of pulmonary metastasectomy: a review article

FPY Cheung, NZ Alam, GM Wright - Annals of Thoracic and …, 2019 - jstage.jst.go.jp
Pulmonary metastases are a sign of advanced malignancy and an omen of poor prognosis.
Once primary tumors metastasize, they become notoriously difficult to treat and …

[HTML][HTML] Pulmonary metastasectomy: an overview

F Petrella, C Diotti, A Rimessi… - Journal of thoracic …, 2017 - ncbi.nlm.nih.gov
Metastasectomy is the most frequent surgical resection undertaken by thoracic surgeons,
being the lung the second common site of metastases. The present oncological criteria for …

Engineered vitamin E-tethered non-immunogenic facial lipopeptide for developing improved siRNA based combination therapy against metastatic breast cancer

AM Mallick, A Biswas, S Mishra, S Jadhav… - Chemical …, 2023 - pubs.rsc.org
RNA interference based therapeutic gene silencing is an emerging platform for managing
highly metastatic breast cancer. Cytosolic delivery of functional siRNA remains the key …

Radical irradiation of extracranial oligometastases

JK Salama, MT Milano - Journal of Clinical Oncology, 2014 - ascopubs.org
Advances in radiotherapy planning and delivery have been used to treat patients with
limited metastatic disease. With these techniques, high rates of treated metastasis control …

Stereotactic radiotherapy for oligometastasis

S Otake, T Goto - Cancers, 2019 - mdpi.com
Oligometastatic disease is defined as “a condition with a few metastases arising from tumors
that have not acquired a potential for widespread metastases.” Its behavior suggests a …

Prolonged overall survival after pulmonary metastasectomy in patients with breast cancer

G Meimarakis, D Rüttinger, J Stemmler… - The Annals of thoracic …, 2013 - Elsevier
BACKGROUND: We investigated whether overall survival (OS) in patients with primary
breast cancer (BC) is prolonged by pulmonary metastasectomy and which prognostic criteria …